Endovenous Laser Ablation of the Saphenous
Veins: Bilateral Versus Unilateral Single-session
Procedures
Bertrand Janne d’Othée, MD, MPH, Salomao Faintuch, MD, Todd Schirmang, MD, and Elvira V. Lang, MD
PURPOSE: To assess the feasibility of bilateral endovenous laser ablation (EVLA) of saphenous veins in a single
session with use of diluted lidocaine for tumescent anesthesia.
MATERIALS AND METHODS: Among 122 consecutive EVLA procedures (112 patients; mean age, 49 years; 75%
women) over a 12-month period, there were 75 unilateral procedures (n 67) and 47 bilateral interventions (n 45).
Tumescent anesthesia consisted of lidocaine diluted to 0.10% for unilateral procedures versus 0.05% for bilateral cases
(lidocaine dose <4.5 mg/kg body weight). Procedural data, immediate success rates on an intent-to-treat basis, and
outcomes at 3– 6-month follow-up were compared between groups with nonparametric tests.
RESULTS: Bilateral procedures could be performed successfully with low lidocaine dilutions with a similar success
rate (96%) as unilateral procedures (100%). No significant variation in systolic and diastolic blood pressure and heart
rate was observed between bilateral and unilateral groups. No patient experienced signs of lidocaine toxicity. After
adjusting for length of vein treated, there were no significant differences in the total lidocaine dose used, tumescent
anesthesia volume, or procedure duration.
CONCLUSIONS: Bilateral saphenous vein ablation in a single session appears safe and effective when tumescent
anesthesia is given with very dilute lidocaine (0.05%). This approach may help meet patients’ requests for simulta-
neous bilateral treatment and reduce duration of postprocedural discomfort.
J Vasc Interv Radiol 2008; 19:211–215
Abbreviations: EVLA = endovenous laser ablation, GSV = great saphenous vein
ENDOVENOUS radiofrequency and
endovenous laser ablation (EVLA)
techniques are gaining popularity for
the treatment of incompetent saphe-
nous veins (1,2). Outpatient treatment
and short recovery are attractive to pa-
tients (3). In our experience, many can-
didates for bilateral saphenous vein
ablation request to have both legs
treated in a single session. A limitation
to this approach lies in the potential
for lidocaine toxicity that may arise
when a large amount of tumescent an-
esthesia is required (4,5). When the
total length of the venous segments to
ablate is small, bilateral treatment can
easily be performed in a single session.
However, for longer segments of the
great saphenous vein (GSV) system,
many practitioners are reluctant to
perform same-day bilateral treatment.
As a result of overwhelming patient
demand, we started performing bilat-
eral, single-session procedures with
use of low lidocaine dilutions for tu-
mescent anesthesia that would pro-
vide appropriate patient comfort level
and reduced risks of drug toxicity.
Herein we report our experience with
bilateral EVLA of the saphenous veins
performed in a single session and
compare it versus unilateral EVLA
procedures in terms of feasibility and
efficacy, with special attention to com-
plications related to local anesthetic
toxicity.
MATERIALS AND METHODS
Patients
This was a retrospective study of all
consecutive EVLA procedures per-
formed over a 1-year period at a single
institution. As part of the quality as-
surance criteria of our routine practice,
all data reported here were encoded
prospectively in our database. Our in-
stitutional review board approved the
retrospective analysis of these data. In-
formed consent for the procedure was
obtained from all patients. Ablation
From the Department of Radiology, Beth Israel Dea-
coness Medical Center–Harvard Medical School,
Boston, Massachusetts. Received April 23, 2007; final
revision received and accepted September 9, 2007.
Address correspondence to B.J.D., Department of
Radiology, Cardiovascular Imaging and Interven-
tion, Massachusetts General Hospital–Harvard
Medical School, 55 Fruit St, GRB-290, Boston, MA
02114-2696; E-mail: bjannedothee@partners.org
None of the authors have identified a conflict of
interest.
© SIR, 2008
DOI: 10.1016/j.jvir.2007.09.010
211